Holland, D P <br/><br/>
Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  06 2016 
 - 827-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.15.0006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--therapeutic use<br/>Decision Support Techniques<br/>Ethambutol--therapeutic use<br/>Humans<br/>Isoniazid--therapeutic use<br/>Markov Chains<br/>Pyrazinamide--therapeutic use<br/>Recurrence<br/>Rifampin--analogs & derivatives<br/>Treatment Outcome<br/>Tuberculosis--drug therapy